Holdgraf Randall W, Kress Melissa
Division of Otolaryngology, Department of Surgery, Texas A&M College of Medicine/Scott and White Memorial Hospital Program, Temple, Texas.
Division of Otolaryngology, Department of Surgery, Baylor Scott and White McLane Children's Hospital, Temple, Texas.
Proc (Bayl Univ Med Cent). 2018 Feb 23;31(2):194-196. doi: 10.1080/08998280.2017.1415547. eCollection 2018 Apr.
Subglottic hemangioma is a potentially life-threatening manifestation of the PHACES syndrome. The disease process has been treated with corticosteroids, oral chemotherapeutic agents, endoscopic airway interventions, tracheostomy, and even laryngotracheal reconstruction. Oral propranolol has emerged as an effective therapy and in many cases has led to complete regression of hemangioma during the proliferative phase. There have been several reports of patients showing signs of reproliferation after discontinuing propranolol therapy. This article illustrates a patient who has had multiple episodes of reproliferation of subglottic hemangioma after weaning from propranolol therapy.
声门下血管瘤是PHACES综合征的一种潜在危及生命的表现。该疾病进程已采用皮质类固醇、口服化疗药物、内镜气道干预、气管切开术甚至喉气管重建进行治疗。口服普萘洛尔已成为一种有效的治疗方法,在许多情况下已导致血管瘤在增殖期完全消退。有几篇报道称患者在停用普萘洛尔治疗后出现再增殖迹象。本文阐述了一名患者在停用普萘洛尔治疗后声门下血管瘤出现多次再增殖发作的情况。